Lung-resident CD69+ST2+ TH2 cells mediate long-term type 2 memory to inhaled antigen in mice
Journal of Allergy and Clinical Immunology · 2023
DOI: 10.1016/j.jaci.2023.01.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2023. Verfasst von Takao Kobayashi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergic Diseases, Asthma and Clinical Immunology, and Department of Medicine, Mayo Clinic, Scottsdale, Ariz. Hauptthemen laut MEDLINE: Interleukin-33, Asthma. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIAID NIH HHS, Mayo Foundation for Medical Education and Research.
Abstract (Originalsprache)
BACKGROUND: Chronic airway diseases such as asthma are characterized by persistent type 2 immunity in the airways. We know little about the mechanisms that explain why type 2 inflammation continues in these diseases. OBJECTIVE: We used mouse models to investigate the mechanisms involved in long-lasting immune memory. METHODS: Naive mice were exposed intranasally to ovalbumin (OVA) antigen with Alternaria extract as an adjuvant. Type 2 memory was analyzed by parabiosis model, flow cytometry with in vivo antibody labeling, and intranasal OVA recall challenge. Gene-deficient mice were used to analyze the mechanisms. RESULTS: In the parabiosis model, mice previously exposed intranasally to OVA with Alternaria showed more robust antigen-specific immune responses and airway inflammation than mice with circulating OVA-specific T cells. After a single airway exposure to OVA with Alternaria, CD69+ST2+ TH2-type T cells, which highly express type 2 cytokine messenger RNA and lack CD62L expression, appeared in lung tissue within 5 days and persisted for at least 84 days. When exposed again to OVA in vivo, these cells produced type 2 cytokines quickly without involving circulating T cells. Development of tissue-resident CD69+ST2+ TH2 cells and long-term memory to an inhaled antigen were abrogated in mice deficient in ST2 or IL-33, but not TSLP receptor. CONCLUSION: CD69+ST2+ TH2 memory cells develop quickly in lung tissue after initial allergen exposure and persist for a prolonged period. The ST2/IL-33 pathway may play a role in the development of immune memory in lung to certain allergens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Allergic Diseases, Asthma and Clinical Immunology, and Department of Medicine, Mayo Clinic, Scottsdale, Ariz.
- Immunology Program, Mayo Clinic Graduate School of Biomedical Sciences, Rochester and Scottsdale, Rochester, Minn.
- Division of Allergic Diseases, Asthma and Clinical Immunology, and Department of Medicine, Mayo Clinic, Scottsdale, Ariz; Department of Immunology, Mayo Clinic, Rochester, and Mayo Clinic, Scottsdale, Ariz. Electronic a…
Förderung
- NCI NIH HHS
- NIAID NIH HHS
- Mayo Foundation for Medical Education and Research
- National Institutes of Health
- NIAID
Zitieren
APA
Kobayashi, T., Iijima, K., Matsumoto, K., Lama, J. K., & Kita, H. (2023). Lung-resident CD69+ST2+ TH2 cells mediate long-term type 2 memory to inhaled antigen in mice. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2023.01.016
Vancouver
Kobayashi T, Iijima K, Matsumoto K, Lama JK, Kita H. Lung-resident CD69+ST2+ TH2 cells mediate long-term type 2 memory to inhaled antigen in mice. Journal of Allergy and Clinical Immunology. 2023. doi:10.1016/j.jaci.2023.01.016
BibTeX
@article{Kobayashi2023,
author = {Kobayashi, Takao and Iijima, Koji and Matsumoto, Koji and Lama, Jyoti K and Kita, Hirohito},
title = {Lung-resident CD69+ST2+ TH2 cells mediate long-term type 2 memory to inhaled antigen in mice},
journal = {Journal of Allergy and Clinical Immunology},
year = {2023},
doi = {10.1016/j.jaci.2023.01.016}
}
EUVIMED